Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Bristol-Myers Squibb
MedImmune LLC
Bristol-Myers Squibb
Nektar Therapeutics
Menarini Group
NuCana plc
HiberCell, Inc.
ImmunityBio, Inc.
Immodulon Therapeutics Ltd
GlaxoSmithKline
ImmunityBio, Inc.
Washington University School of Medicine
Pharmacyclics LLC.
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Eisai Inc.
Eli Lilly and Company
University of Chicago
Daiichi Sankyo
Gilead Sciences
Novartis
University of Texas Southwestern Medical Center
Stanford University
Western Regional Medical Center
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Dana-Farber Cancer Institute
University of California, Davis
Hoosier Cancer Research Network
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Duke University
Emory University
Merck KGaA, Darmstadt, Germany